Suomija – Sistemiškai veikiantys priešinfekciniai vaistai ir vakcinos – PRIDEDAMAS INFORMACINIS PASTABINIMAS: sisteminio naudojimo antibakteriniai ir antimikobakteriniai preparatai

Ted skelbimo peržiūra

Suomija – Sistemiškai veikiantys priešinfekciniai vaistai ir vakcinos – PRIDEDAMAS INFORMACINIS PASTABINIMAS: sisteminio naudojimo antibakteriniai ir antimikobakteriniai preparatai

I dalis: Perkančioji organizacija

I.1) Pavadinimas ir adresai:

Oficialus pavadinimas: Finnish Institute for Health and Welfare

Adresas: PL 30

Miestas: Helsinki

Pašto kodas: 00271

Šalis: Suomija

Asmuo ryšiams:

El-paštas: kilpailutus@thl.fi

Interneto adresas (-ai):

Pagrindinis adresas: http://www.thl.fi/

II dalis: Objektas

II.1.1) Pavadinimas:

PRIOR INFORMATION NOTICE: Antibacterial and antimycobacterial products for systemic use

Nuorodos numeris: THL/5372/2.02.06/2024

II.1.2) Pagrindinis BVPŽ kodas:

33651000 Farmacijos produktai ;

II.1.3) Sutarties tipas:

Kita

;

II.1.4) Trumpas aprašymas:

Finnish Institute for Health and Welfare, later referred to as THL or Customer, is about to publish a call for tenders for antibacterial and antimycobacterial products for systemic use. The date of publication of the call for tenders is planned for October 2024. The scope of procurement is described in more detail in Annex 1. The procurement will be divided in twelve (12) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots. - LOT 1: Moxifloxacin 400 mg / 250 ml (250 ml, i.v. solution, ATC J01MA14) - LOT 2: Linezolid 2 mg/ml (300 ml, i.v. solution, ATC J01XX08) - LOT 3: Linezolid 600 mg (tablet/capsule, oral, ATC J01XX08) - LOT 4: Pyrazinamide 500 mg (tablet/capsule, oral, ATC J04AK01) - LOT 5: Etambuthol 500 mg (tablet/capsule, oral, ATC J04AK02) - LOT 6: Clindamycin 300 mg (tablet/capsule, oral, ATC J01FF01) - LOT 7: Isoniazide 300 mg (tablet/capsule, oral, ATC J04AC01) - LOT 8: Claritromycin 250 mg (tablet/capsule, oral, ATC J01FA09) - LOT 9: Clindamycin 15 mg/ml (80 ml, oral suspension, ATC J01FF01) - LOT 10: Moxifloxacin 400 mg (tablet/capsule, oral, ATC J01MA14) - LOT 11: Levofloxacin 500 mg (tablet/capsule, oral, ATC J01MA12) - LOT 12: Claritromycin oral suspension 50 mg/ml (50 ml, oral suspension ATC J01FA09) The minimum requirements for the products is described in Annex 1.1. The contract will be awarded to one supplier for each lot based on a comparison of tenders. Estimated quantity for the products is described in Annex 1.2 (restricted to security classification level IV, TL IV). In addition to the estimated quantity indicated in the Annex 1.2, the Customer is entitled to purchase 100 % extra to the estimated quantities (later referred as "Option"). The supplier is not obliged to deliver the products under the Option. THL reserves the right to change the scope of the procurement and the minimum requirements in the published call for tenders.

II.2) Aprašymas:

II.2.1) Kitas (-i) šio pirkimo BVPŽ kodas (-ai):

33600000 Farmacijos produktai

33651000 Sistemiškai veikiantys priešinfekciniai vaistai ir vakcinos

Daugiau informacijos apie šį skelbimą rasite spustelėje NUORODĄ